Faeth Therapeutics
FTH----
Faeth Therapeutics (FTH)
Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offe...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Faeth Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 20, 2026Price forecast
$54.0090.88%
Forecast & RatingStrong buy
8analysts
- Strong buy87.50%
- Buy12.50%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 1 day ago, 04:52 PM
Faeth Therapeutics Adopts Performance-Based Stock Option Plan
- TradingView · 1 day ago, 04:23 PM
Faeth Therapeutics grants performance options to Anand Parikh, Christopher Gerry and Josiah Craver
- PUBT · 1 day ago, 03:00 PM
Faeth Therapeutics grants new-hire stock options for 25,500 shares at $28.19 each
- Global Report · 2 days ago, 04:18 AM
Market Insider: A $200M Energy Buyout and Niche Sector Overhauls
- rttnews · Jul 13 at 06:18 AM
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH
- StockTitan · Jul 3 at 07:00 AM
Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | FTH Stock News
